Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease

BACKGROUND: Complement proteins and activation products have been found associated with neuropathology in Alzheimer's disease (AD). Recently, a C5a receptor antagonist was shown to suppress neuropathology in two murine models of AD, Tg2576 and 3xTg. Previously, a genetic deficiency of C1q in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Fonseca, Maria I, Chu, Shu-Hui, Berci, Alisia M, Benoit, Marie E, Peters, Douglas G, Kimura, Yuko, Tenner, Andrea J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033336/
https://www.ncbi.nlm.nih.gov/pubmed/21235806
http://dx.doi.org/10.1186/1742-2094-8-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033336/
https://www.ncbi.nlm.nih.gov/pubmed/21235806
http://dx.doi.org/10.1186/1742-2094-8-4

Ejemplares similares